4th Quarter - Report

THE RUSSELL GROUP, INC. for GENERIC PHARMACEUTICAL ASSOCIATION

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

S. 515, H.R. 1260, Patent Reform Act of 2009 - Issues relative to patent quality

LobbyistCovered position, as disclosed
EDWARD BARRON —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA); Office of Management & Budget (OMB)

Bills named: S. 515 (111th), H.R. 1260 (111th)

Pharmacy PHA

Issues relative to generic pharmaceuticals and generic biologics; H.R. 2997, S. 1406 - 2010 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Bill (Title VI - Related Agencies and Food and Drug Administration Department of Health and Human Services); H.R. 1427, S. 726 - Promoting Innovation and Access to Life-Saving Medicine Act (entire bill); S. 369 - Preserve Access to Affordable Generics Act (entire bill)

LobbyistCovered position, as disclosed
EDWARD BARRON —
TYSON REDPATH —
RANDALL RUSSELL —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Food & Drug Administration (FDA)

Bills named: S. 369 (111th), H.R. 1427 (111th), S. 1406 (111th), S. 726 (111th), H.R. 2997 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.